Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Volume: 382, Issue: 16, Pages: 1507 - 1519
Published: Apr 16, 2020
Abstract
Inclisiran inhibits hepatic synthesis of proprotein convertase subtilisin–kexin type 9. Previous studies suggest that inclisiran might provide sustained reductions in low-density lipoprotein (LDL) cholesterol levels with infrequent...
Paper Details
Title
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Published Date
Apr 16, 2020
Volume
382
Issue
16
Pages
1507 - 1519
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History